122 related articles for article (PubMed ID: 20213894)
1. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
Odinak MM; Lobzin VIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894
[No Abstract] [Full Text] [Related]
2. [Vinpotropile in the treatment of cerebral vascular diseases].
Filimonov VA; Kliueva VN; Kondrasheva IN
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
[No Abstract] [Full Text] [Related]
3. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
Chukanova EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831
[TBL] [Abstract][Full Text] [Related]
4. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
[No Abstract] [Full Text] [Related]
5. [Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment].
Gavrilova SI; Kolykhalov IV; Fedorova IaB; Selezneva ND; Kalyn IaB; Roshchina IF; Odinak MM; Emelin AIu; Kashin AV; Gustov AV; Antipenko EA; Korshunova IuA; Davydova TA; Messler G
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):62-9. PubMed ID: 20436440
[TBL] [Abstract][Full Text] [Related]
6. [The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
Doronin BM; Popova TF; Kornach NV; Klimova LA; Volkova II; Chelysheva LV
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):48-50. PubMed ID: 19253466
[No Abstract] [Full Text] [Related]
7. [The results of using lucetam in patients with moderate cognitive impairment of different genesis].
Batysheva TT; Otcheskaia OV; Nesterova ON; Lisinker LN; Bobina LA; Ismailov AM; Shekkhirimov RK; Zhuravleva EIu; Kamchatnov PR; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):63-5. PubMed ID: 19255983
[No Abstract] [Full Text] [Related]
8. [The new scheme of cavinton application to the treatment of chronic neurosensory loss of hearing].
Afon'kin VIu; Dobretsov KG; Sipkin AV
Vestn Otorinolaringol; 2009; (6):69-70. PubMed ID: 20081798
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of circulatory encephalopathy with Cavinton].
Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
[No Abstract] [Full Text] [Related]
10. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
11. [About cavinton therapy of the patients with brain vascular diseases].
Nikitina VV; Pravdina AN; Zapatrina OV
Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
[No Abstract] [Full Text] [Related]
12. [The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
Spirin NN; Pizova NV; Shadrichev VA; Filatov VF; Bakucheva MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):64-6. PubMed ID: 18688926
[No Abstract] [Full Text] [Related]
13. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
[No Abstract] [Full Text] [Related]
14. [Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
Grigor'eva AN; Nesterova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):90-1. PubMed ID: 19708280
[No Abstract] [Full Text] [Related]
15. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of dynamic magnetic therapy in the complex treatment of cognitive disturbances in patients with chronic cerebrovascular insufficiency].
Orekhova EM; Svistunov AA; Konchugova TV; Prikazchikova OA; Raĭgorodskiĭ IuM
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):59-62. PubMed ID: 19385120
[No Abstract] [Full Text] [Related]
17. [The use of pantogam in patients with moderate cognitive disorders of vascular genesis].
Mikhaĭlova NA; Kamchatov PR
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):47-50. PubMed ID: 20879105
[TBL] [Abstract][Full Text] [Related]
18. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
Lebedeva NV; Khrapova EV
Sov Med; 1990; (1):60-3. PubMed ID: 2190329
[No Abstract] [Full Text] [Related]
19. [Cognitive disturbances and dysfunction of neuromediator systems in cerebral vascular insufficiency after treatment with pronoran].
Bugrova SG; Novikov AE
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):63-5. PubMed ID: 18689025
[No Abstract] [Full Text] [Related]
20. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
Chukanova EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
